参考文献/References:
[1] Ponikowski P, Voors A A, Anker S D, et al.2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC)Developed with the special contribution of the Heart Failure Association(HFA)of the ESC[J]. Eur Heart J, 2016,37(27): 2129-2200.
[2] Gazoti Debessa C R, Mesiano Maifrino L B, Rodrigues de Souza R.Age related changes of the collagen network of the human heart[J]. Mech Ageing Dev, 2001, 122(10): 1049-1058.
[3] Ahmed N.Advanced glycation endproducts--role in pathology of diabetic complications[J]. Diabetes Res Clin Pract,2005, 67(1): 3-21.
[4] 方敏, 李世玲, 王俊宏,等.晚期糖基化终产物对心肌成纤维细胞的老化及纤维化的影响[J]. 南京医科大学学报:自然科学版, 2014, 34(1): 22-26.
[5] Wang Y, Luo W, Han J, et al.MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy[J]. Nat Commun,2020,11(1): 2148.
[6] Thorpe S R, Baynes J W.Maillard reaction products in tissue proteins: new products and new perspectives[J]. Amino Acids,2003,25(3-4): 275-281.
[7] Yang P, Feng J, Peng Q, et al.Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes[J]. Oxid Med Cell Longev, 2019, 2019: 9570616.
[8] Yamagishi S, Maeda S, Matsui T, et al.Role of advanced glycation end products(AGEs)and oxidative stress in vascular complications in diabetes[J]. Biochim Biophys Acta, 2012, 1820(5): 663-671.
[9] Domingueti C P, Dusse L M, Md C, et al.Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications[J]. J Diabetes Complications, 2016,30(4): 738-745.
[10] Hou X, Hu Z, Xu H, et al.Advanced glycation endproducts trigger autophagy in cadiomyocyte via RAGE/PI3K/AKT/mTOR pathway[J]. Cardiovasc Diabetol, 2014,13(4): 78.
[11] 郑炜平, 朱鹏立, 余惠珍.替米沙坦对自发性高血压大鼠晚期糖基化终末产物及其受体表达水平影响及机制的研究[J]. 福建医药杂志, 2013,35(6): 7-9.
[12] 郑炜平, 朱鹏立, 李峰,等.吡哆胺和替米沙坦对自发性高血压大鼠心肌重塑相关指标的影响[J]. 中国循环杂志,2015,30(7): 689-693.
[13] Takeuchi O, Akira S.Toll-like receptors; their physiological role and signal transduction system[J]. Int Immunopharmacol, 2001, 1(4): 625-635.
[14] Wang Y, Shan X, Chen G, et al.MD-2 as the target of a novel small molecule, L6H21, in the attenuation of LPS-induced inflammatory response and sepsis[J]. Br J Pharmacol, 2015,172(17): 4391-4405.
[15] Lin M, Yiu W H, Wu H J, et al.Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy[J]. J Am Soc Nephrol,2012,23(1): 86-102.
[16] Liu Z W, Wang J K, Qiu C, et al.Matrine pretreatment improves cardiac function in rats with diabetic cardiomyopathy via suppressing ROS/TLR-4 signaling pathway[J]. Acta Phar-macol Sin,2015, 36(3): 323-333.
相似文献/References:
[1]曹木根,游濠乐,陈乐昀,等.晚期糖基化终产物通过TLR4/MD2通路介导心肌细胞炎症的机制研究[J].福建医药杂志,2024,46(07):64.[doi:10.20148/j.fmj.2024.07.021]
CAO Mugen,YOU Haole,CHEN Leyun,et al.Study on mechanism of AGEs mediating inflammation of cardiomyocytes through TLR4/MD2 pathway[J].FUJIAN MEDICAL JOURNAL,2024,46(01):64.[doi:10.20148/j.fmj.2024.07.021]